TRANSCRIPT

Q2 2020 — Fixed income call transcript

Q2 2020PDF · 21 pages199 KB
Deutsche Bank AG
Q2 2020 Fixed Income Conference Call
July 31st, 2020 | 14:00 CEST
Speakers:
James von Moltke
Dixit Joshi
Philip Teuchner

-- 1 of 21 --

Philip Teuchner 	Thank you, Emma. Good afternoon or good morning, and thank you
all for joining us today. On the call, as always, our CFO, James von
Moltke, will speak first. Then, our Group Treasurer, Dixit Joshi, will
take you through some fixed income-specific topics. In the room for
Q&A we also have Jonathan Blake, our Global Head of Issuance &
Securitization and Ralf Leiber, Head of Group Capital Management.
The slides that accompany the topics are available for download from
our website at db.com.
After the presentation, we'll be happy to take your questions but,
before we get started, I just want to remind you that the presentation
may contain forward-looking statements which may not develop as
we currently expect. Therefore, please take note of the precautionary
warning at the end of our materials. With that, let me hand over to
James.
James von Moltke 	Thank you, Philip, and welcome from me. Let me start with a summary
of our financial performance in the second quarter on slide three.
Revenues of €6.3 billion increased by 1% as growth in the Core Bank
offset the exit from Equities trading.
Non-interest expenses of €5.4 billion included an additional €116
million of bank levies compared to the second quarter of last year, as
well as €445 million of restructuring and severance, litigation and
transformation charges. Non-interest expenses in the prior year
period included €1.0 billion of goodwill impairments and €350 million
of transformation charges. Provision for credit losses was €761 million
or the equivalent of 69 basis points of loans on an annualised basis.
We generated a pre-tax profit of €158 million or €419 million on an
adjusted basis, excluding items detailed on slide 39 of the appendix.
As Dixit will discuss later, our liquidity position was strong as both
reserves and LCR rebounded from first quarter levels.
Slide four updates a chart we showed you last quarter, with the
management estimates of the most material impacts of the COVID-19
pandemic. Compared to the first quarter, results in the second quarter
saw a more rapid normalisation of some of these impacts than we
initially anticipated, in particular capital and liquidity reserves.
Incremental provisions for credit losses related to COVID-19 were
approximately €410 million, which I will discuss shortly. There was a
positive impact of approximately 12 basis points on our CET1 ratio
from COVID-19.
Increases in market risk RWA, reflecting higher market volatility and
higher Credit Risk RWA from ratings migrations, were more than
offset by several impacts. These included the repayment of credit

-- 2 of 21 --

facilities, lower derivative exposures and the reversal of most of the
increase in prudent valuation adjustments recorded in the first
quarter.
The repayment of committed credit facilities and reduced client
demand for lending increased liquidity reserves by €12 billion. And,
finally, Level 3 assets of €25 billion decreased by €2.0 billion. The
decline reflected the partial reversal of the first quarter migration of
assets into Level 3, which had resulted from the greater dispersion in
market pricing at the end of the first quarter, as well as reduced
balance sheet carrying values.
Looking forward, the path of the pandemic remains uncertain, but we
see the developments in the quarter as positive. Our strategy is
focused on improving sustainable profitability by generating positive
operating leverage through a reduction of costs and growth in
revenues.
As shown on slide five, operating leverage has been positive for three
quarters in a row for both Group and Core Bank, driving significant
improvements in Core Bank profitability. Over the last 12 months,
Core Bank adjusted profit before tax has grown by 18% to €3.1 billion.
Core Bank profitability has enabled us to absorb the costs of de-risking
in the CRU, where the reduction of risk-weighted assets is running as
we anticipated. As we make further progress with the wind-down of
the CRU, the underlying performance of the Core Bank should become
more visible in our group results.
You can see that on slide six. Core Bank revenues were €23.7 billion
over the last 12 months. At the Investor Deep Dive, we showed a 2022
revenue plan of €24.5 billion, consistent with an 8% return on tangible
equity target. This implies an annual revenue growth rate of around
2% from current levels and compares to the 5% growth that we have
reported in the Core Bank in the last 12 months.
With the client momentum that we have created and the changes we
have made to our business model, we're confident of achieving these
plans even when current market dynamics normalise.
Slide seven shows some of the key revenue drivers. The Corporate
Bank operates in an attractive market despite the challenges of the
current interest rate environment. We've demonstrated that we can
largely offset these headwinds with repricing and volume growth.
We've grown corporate cash transactions by 8% and loans by 1% over
the last 12 months.
The Corporate Bank has also been essential in supporting corporates,
including in Germany. Combining all the German government

-- 3 of 21 --

programmes, we have been the most active bank in this space.
In the Investment Bank, our strategy is to focus on our core strengths.
Overall, revenues in Fixed Income & Currencies grew by 39% year-on-
year with FIC trading, excluding financing and specific items, up by
more than 75%. We achieved this performance with broadly stable
levels of RWA, excluding regulatory inflation. This demonstrates
efficient resource utilisation and is enabled by a combination of
prudent risk management and higher quality client flow.
In the Private Bank, we're focused on offsetting the pressure from
negative interest rates with volume growth. In the second quarter, the
Private Bank captured €5.0 billion of net inflows in investment
products and €3.0 billion of net new client loans.
Unsurprisingly, 	new 	consumer 	loans 	and 	investment 	products
declined during the lockdown. With the reopening towards the end of
the second quarter, we are now seeing a rebound in volumes, in some
areas even tracking above last year.
In Asset Management, we're building on the momentum that DWS
has generated. Inflows were €9.0 billion in the quarter. Assets under
management increased by €45 billion in the quarter and €24 billion
over the last 12 months. Asset Management also implemented
further decisive cost measures in direct response to the COVID-19
environment.
We remain determined not to let the current environment disrupt our
cost reduction plans. We've now reduced adjusted costs, excluding
transformation charges and bank levies, for the tenth consecutive
quarter as you can see on slide eight.
Year-on-year, adjusted costs declined by 8% to €4.9 billion. The
further progress we have made in the second quarter puts us on a
good path to achieve or outperform against our €19.5 billion target
for 2020.
Turning to provision for credit losses on slide nine, provisions were
€761 million in the quarter. As I just mentioned, a little over half or
€410 million of these provisions related to COVID-19 impacts.
Approximately half of the COVID-19 provisions are against Stage 1 and
Stage 2 credits with the remainder against Stage 3 loans. Stages 1 and
2 provisions reflect the weaker macroeconomic outlook relative to
March 31, a management overlay to account for uncertainties in the
outlook as well as downgrades to client credit ratings. Consistent with
our guidance, Stage 3 provisions increased in the quarter and were
mostly in the Investment Bank.

-- 4 of 21 --

Including the provisions taken in the first quarter, we ended the
period with €4.9 billion of allowance for loan losses equivalent to 112
basis points of loans. As a reminder, we feel this level of provisioning
is in line with our peers on a risk-adjusted basis, calibrated to the
relative exposure to consumer credit lending.
Let us turn to the broader macroeconomic outlook on slide ten. We
continue to expect a robust recovery in some major economies
starting in the second half of this year, although it will take longer to
return to the pre-COVID GDP levels than initially anticipated.
The EU stimulus package should support the economic recovery in
Europe, including our home market, Germany, beginning in 2021.
We're happy to have a leadership position in Europe's strongest
economy, which is proving its resilience. Germany came in into the
crisis with low levels of debt. This fiscal conservatism has allowed the
government to take aggressive and decisive action in response.
Germany benefits from a combination of an effective social security
system, 	one 	of 	the 	largest 	loan 	and 	guarantee 	programmes
worldwide, and €130 billion in certain stimulus packages. Economists,
therefore, expect Germany to suffer less and to recover quicker than
most many other countries. This economic stability comes together
with low levels of household and corporate debt, a historically stable
housing market, as well as good levels of corporate liquidity relative
to other leading economies. Therefore, German companies and
consumers are in a relatively better position to weather the current
environment.
All of this contributes to the resilience of our German loan book, which
accounts for about half of our total loan portfolio. But, of course,
uncertainties will persist for the time being. We must not be
complacent and have to continue to execute on our transformation
agenda.
Let me summarise our progress on page eleven. Looking back on the
first year of our transformation, we're on track with or even ahead of
the objectives that we set ourselves. Our new strategy is paying off.
The momentum we have within the Core Bank more than offset the
wind down of the Capital Release Unit, elevated provisions for credit
losses from the pandemic and transformation impacts.
We therefore are confident that we will reach our 2022 targets and
show a clear path with being profitable in the second quarter and in
the first half of the year. By now, over three-quarters of our expected
transformation charges are already behind us and we have achieved
this with both capital and liquidity being stronger than our internal
plans at the end of the second quarter.

-- 5 of 21 --

This positions us well to continue supporting our clients through
conditions which remain challenging. We also continue to work on our
technology, including the partnership with Google, which aims to
improve offerings to clients and infrastructure efficiency. And finally,
we shaped our sustainability strategy and issued our first green bond.
With that, let me hand over to Dixit.
Dixit Joshi 	Thank you, James. As we execute on our transformation, we will
continue to balance, manage our balance sheet conservatively. Slide
13 repeats a slide that we have shown you before. You can clearly see
the impact of COVID-19 in our Q1 financials. Results in the second
quarter saw a more rapid normalisation of some of these impacts than
we originally expected and, in particular, capital and liquidity reserves.
As we announced last week, we ended the quarter with a CET1 ratio
of 13.3%. This reflects lower loan balances driven by higher-than-
expected repayments of credit facilities by clients that were initially
drawn in reaction to COVID-19. In part, these facilities have been
refinanced through debt capital markets instruments.
While loans declined in the second quarter, they are still up by €8.0
billion since year-end 2019. Our loss-absorbing capacity was €19
billion above our most binding MREL constraint, stable versus the
prior quarter. We are one of the few European G-SIBs that already
comply with the fully-loaded requirements.
Liquidity reserves increased significantly over the quarter to €232
billion. Our solid capital and liquidity position gives us scope to
continue to deploy resources to support clients through challenging
conditions.
We are also focused on maintaining strong credit quality. Provisions
for credit losses of €761 million in the quarter are consistent with our
previous guidance and our full year outlook. This reflects our
conservative underwriting standards and the low-risk nature of our
loan book. As we have communicated before, our exposure to credit
cards and other unsecured consumer lending is low relative to our
international peers.
Let us now look at our net balance sheet on slide 14. This view
excludes derivative spending, netting agreements, cash collateral and
pending settlement balances from our IFRS balance sheet to make it
more comparable to US-GAAP accounting standards. We have
structurally changed our balance sheet and created a more stable and
efficient base that has allowed us to manage through recent events
while keeping our transformation on track.
Liquidity reserves account for roughly a quarter of the net balance

-- 6 of 21 --

sheet. Our loan-to-deposit ratio declined slightly and, at 77%, provides
significant room to conservatively grow loans in coming periods.
Funding from most stable sources represents 81% of our net balance
sheet, or 85% including TLTRO.
Looking now a bit closer at our capital ratios starting on slide 15. Our
CET1 ratio of 13.3% at quarter-end increased by 42 basis points
sequentially. This includes an approximately 12 basis point increase
from COVID-19 effects, as James discussed earlier. Approximately 11
basis points of the ratio increase came from regulatory changes
associated with the CRR Quick Fix. These changes included the
application of the revised SME support factor as well as the first-time
application of the IFRS 9 transitional approach.
Excluding COVID-19 and CRR Quick Fix impacts, we saw approximately
13 basis points of improvement from continued de-risking in the
Capital Release Unit. Additionally, the Core Bank generated seven
basis points, principally reflecting lower risk-weighted assets in the
Investment Bank and Corporate Bank.
The buffer above regulatory requirements for the CET1 ratio
increased by 44 to 283 basis points, as shown on slide 16. The total
capital ratio was 17.5% at quarter-end. Here, we have increased our
buffer by 90 basis points in the quarter to 245 basis points.
Including the Tier 2 issuance from late June, which only settled in July,
the buffer increases to around 260 basis points on a pro forma basis.
This translates into an equivalent of €9.0 billion headroom in capital
terms.
Despite the challenging market conditions for much of this year, we
have successfully issued around €3.0 billion of Tier 1 and Tier 2
instruments to optimise our capital position and to increase our
distance to MDA. This serves us well to support clients through the
coming periods.
Our leverage ratio was 4.2% at quarter end, an increase of 20 basis
points, as shown on slide 17. Approximately 16 basis points of the
improvement came from the change to a net treatment of pending
settlement 	payables and 	receivables. This change 	follows 	the
implementation of the CRR Quick Fix and was an acceleration of a
previously agreed rule change that would ordinarily have taken effect
only from June 2021. This approach now aligns European banks with
long-established practice at US banks and Swiss peers.
Foreign 	exchange 	translation 	and 	Tier 	1 	capital 	movements
contributed approximately five basis points. Excluding central bank
cash from leverage exposure, consistent with the flexibility provided

-- 7 of 21 --

by the CRR Quick Fix would, if implemented, further increase our
leverage ratio by approximately 20 basis points to 4.4%. Our leverage
ratio is already well above the requirement of 3.75%, which we expect
to apply from January 2023.
Both liquidity reserves and liquidity coverage ratio increased in the
quarter, as you can see on slide 18. The increase reflected higher cash
balances, a trend that we have seen across the sector.
Loans declined by €17 billion as clients began to repay credit facilities
that were drawn in the first quarter. Customer deposits increased by
€9.0 billion across the Corporate and Private Bank, offset by €3.0
billion lower wholesale funding deposits.
We also participated in Central Bank open market operations,
including TLTRO III. As a result, we ended the quarter with liquidity
reserves of €232 billion and a liquidity coverage ratio of 144%, both
well above our targets. Over time, we will prudently manage that
towards our target levels, although given the unprecedented events
in the first half of the year, we feel comfortable operating with a
temporary excess.
Slide 19 shows the substantial progress that we have made in passing
through negative interest rates to our existing corporate and high net
worth customers. At the end of the second quarter, we had charging
agreements in place for around €60 billion of deposits generating
revenues of €45 million in the quarter. That is already ahead of our
full year goal and is on track to contribute well over €100 million of
revenues on an annual basis. The positive revenue development is
predominantly driven by higher deposit retention.
Looking ahead, as our implementation focus will increasingly shift
towards clients with smaller balances, the trend of deposits and scope
for deposit charging as well as the associated revenues is expected to
flatten in the coming quarters. In our Private Bank in Germany, we
have changed our pricing policy and now pass on negative interest
rates to new accounts above €100,000 as announced last quarter. Our
key priority, however, remains to actively engage with our customers
and advise on liquidity solutions and alternative investment products
to help clients offset the negative interest rate environment.
We continue to operate with a significant loss-absorbing capacity well
above our requirements, as shown on slide 20. At the end of the
second quarter, our loss-absorbing capacity was €19 billion, above the
minimum required eligible liabilities or MREL, our most binding
constraint.
In 2021, we expect a few changes to affect our loss-absorbing

-- 8 of 21 --

capacity, including: a de-recognition of bonds issued under U.K. law
following Brexit, the switch from a TLOF-based to an RWA-based
MREL 	requirement, 	a 	higher 	subordinated 	MREL 	requirement
becoming applicable post changes in European law at the end of this
year, and we will see reductions in eligible liabilities in the second half
of this year from outstanding senior non-preferred issuances falling
below the one-year maturity threshold, which are not fully offset by
new issuances. Nevertheless, given our significant buffer, we are well
positioned to absorb these regulatory changes.
Slide 21 shows our updated issuance plan. We reaffirm our previous
guidance of an issuance plan between €10 billion and €15 billion in
aggregate but have amended the composition from the previous
quarter.
During the second quarter, we issued €3.7 billion, taking our year-to-
date issuance to close to €10 billion. Of note, in the quarter we issued
Euro and US dollar Tier 2 and our inaugural green senior preferred
bond. The Tier 2 issuances put us in a comfortable position as they
increased our buffer above regulatory requirements by a further 50
basis points.
The inaugural green bond issuance marks an important step in our
sustainability strategy and forms part of our target of at least €200
billion of sustainable financing and green investment products by
2025.
In terms of the rest of the year, the majority of our issuance is likely
to be in senior non-preferred format. Given our strong liquidity
position and modest requirements, we will be flexible in terms of
timing.
Looking further into the future, we believe that our balance sheet
composition requires less market funding than in the past and we can
manage with lower issuance volumes. For example, we don't need to
refinance 	the 	€17 	billion of senior non-preferred instruments
maturing in 2021.
As part of our overall funding strategy, we raised €30 billion through
the ECB's TLTRO III programme. We may increase our take-up towards
the maximum capacity of approximately €40 billion in future rounds.
In conclusion, on slide 22, we have successfully navigated the initial
impacts of the COVID-19 pandemic. Our balance sheet remains low-
risk and funded by highly stable sources. The improvements we have
made to the composition of our balance sheet, combined with the
investments in our technology, allow us to more accurately and
effectively manage our resources. The progress we have made in

-- 9 of 21 --

these areas is also reflected in the positive outcomes of recent
regulatory stress test, including CCAR.
On the CET1 ratio, a lot of uncertainty remains regarding the
economic environment, client behaviour and potential regulatory
actions. That said, given where we ended the second quarter, we
currently see significant room to continue supporting clients while
maintaining the ratio above our 2022 target of 12.5%. We expect to
prudently manage down our liquidity buffers towards our target levels
over time and, consistent with our previous guidance, we expect
provision for credit losses of 35 to 45 basis points of loans for the full
year.
In summary, we will continue the disciplined execution that you have
seen from this management team over the last few years. Consistent
delivery on our transformation path is also a critical factor for the
ratings agencies. All agencies, the majority of which have published
longer ratings reports in July, acknowledge our progress. A recent
example is the removal from negative watch by Fitch.
Execution on our short-term objectives keeps us on the path to deliver
our 2022 targets. These include a significant improvement in organic
capital generation with a target of post-tax return on tangible equity
of 8%. At the same time, we are focused on maintaining a strong CET1
ratio and improving the leverage ratio over time. With that, let us
move to your questions.
Q&A session
Robert Smalley (UBS) 	Hi. Good morning, good afternoon and thanks for doing the call. A
couple of questions. First, if we could touch on slide 28 in the
appendix, and this is an update from the deep dive on risk.
When we look at these risk mitigation numbers in the clear boxes,
could you talk about the commercial real estate exposure there and
how you're thinking, in general, about commercial real estate, given
what's going on and how that ties in at all with your overall
commercial real estate outstanding? That's my first question.
Second question, we're just seeing a lot of government programmes
coming in, in Germany. How are you looking through that and trying
to make sure that once we get to the other side of some of that, we
don't have a cliff-like experience in terms of credit quality?
And then, finally, on funding. Number one, Dixit, you just mentioned

-- 10 of 21 --

that €17 billion number is probably not going to be as large. If you
could give us some kind of area for 2021 in terms of senior non-
preferred funding. Is it similar to what we're seeing this year, number
one? And, number two, you did a Tier 2 deal in US dollars. You paid a
pretty high coupon for it. Does this lead you to think about doing more
issuance in Euro, sterling and other currencies? Thanks.
Dixit Joshi 	Rob, this is Dixit. I will kick off with sort of the latter questions, and
then James will jump in on the prior ones. On the 2021 maturities that
we have, as I said in my prepared remarks, the €17 billion that we have
actually does roll off through the course of the next 6 months. If you
think about the first 6 months of next year is already effectively
deducted from our MREL calculations already and reflected in the
surplus of €19 billion that we have.
Furthermore, between now and December, the rest of that €17 billion
rolls out of our MREL calculation and so very much being factored into
our issuance plan and requirements for next year.
As I've said, as a result of the deleveraging of our balance sheet and
the move to a much more stable funding base and a greater reliance
on deposit funding, that does afford us more flexibility in senior non-
preferred issuance and on balance, compared to years prior, as you've
seen, we have a lower reliance on capital markets issuance.
That does play a part as well in our revised issuance plan or the mix of
the issuance plan between now and year-end, which as you see from
a senior non-preferred perspective, has a range of up to another €3.0
billion to €4.0 billion of issuance between now and year-end and that
reflects some pre-funding of commitment that we might have for next
year. And so, all in all, we're being appropriately conservative when
we look at our funding plan but in summary, the €19 billion surplus on
MREL affords us a lot of flexibility.
On the second point, what you've seen is you have seen us diversify
the currency mix to the extent we see pockets of it of investor
demand. And, yes, I agree with you to the extent that, again, pricing
lends 	itself 	to 	opportunities. 	It's 	something 	that 	we 	will 	be
considering.
As we stand right now, we've done around €3.0 billion of issuance. In
capital instruments in the first half of the year, which affords us a lot
of flexibility around timing going forward. I hope that's helpful.
James von Moltke 	Robert, it's James. On the first two questions on risk mitigation. The
CRE portfolio is now at about €30 billion. If you look at the slide that
we provide that you referred to, slide 28, it does skew to the non-
investment-grade in those buckets, but I couldn't give you the details

-- 11 of 21 --

of how much in each bucket.
To be honest, our outlook for that segment is sort of unchanged to
our earlier discussions. We've been watching it extremely carefully
given the impact of the pandemic on commercial real estate.
I think the starting point for us was a strong one, given that as we
came into the crisis, loan-to-values were at around 60% of the
portfolio and while, of course, there's been an impact on the cash
flowing of the projects and the valuations of commercial real estate,
we continue to think the portfolio is resilient and, to date, there have
been very few defaults. So, we're watching it extremely carefully, as
you can imagine.
We've also, by the way, seen some secondary liquidity develop in that
market and where we have, and we've executed that the valuations
have been pretty much in line with our views and marks. So, again, it's
trended in line with our original outlooks.
On the government programmes, it's also a very good question. It's
something we're watching carefully because of the fear that there's a
cliff effect. Now a couple of things that I'd say, first of all, while the
legislative moratoria are rolling off, there have been a number of
actions that the industry has done on a voluntary basis.
So, if I think about households, they're getting support from the
government, and the banking industry is continuing to support them
and, to date, where we haven't seen sort of a cliff effect, although
naturally that could still lie ahead.
In terms of the future, our sense is the KfW programme, as an
example, is still open in Germany and actually, we've been surprised,
if anything, at the lesser take-up than we might have expected. So, our
assumption is that some of the liquidity demand has been simply
pushed into later quarters but there is still support for the corporate
balance sheet out there.
And, of course, some of the both fiscal and monetary support in
Europe is coming later than is the case in the States. The recovery
package that the EU agreed on, it only starts on 1st January '21 and,
of course, fiscal support is ramping up with asset purchases. So, as we
sit here today, we don't see that cliff effect, but it's something we're
very watchful around.
Christy Hajiloizou (Barclays) 	Hi, everyone. I have three-and-a-half questions. The first one is on the
stressed net liquidity position. You disclosed that in your quarterly
report and I noticed that, obviously, in the first quarter, that was
negative, but it seems to bounce back quite nicely in the second

-- 12 of 21 --

quarter.
You 	referred 	to, 	obviously, 	a 	normalisation 	in 	the 	economic
environment but you also refer to countermeasures that you've
deployed and sort of methodology enhanced. I'd be curious actually
what some of those look like. If you could just explain what proactive
measures you've taken on your side to improve that.
The second question is on loss-absorbing capacity. You obviously still
have a strong MREL and TLAC buffer over your binding level but on
the slide 20, you are flagging up some headwinds, which went
through, for example, a higher subordination requirements and the
exclusion of UK law, etc. Can you elaborate more around those
expected changes and how it affects your buffers?
And then my third question, I was curious on your IFRS 9 assumptions,
I was reading the quarterly and you have a table showing available
forward-looking information and I noticed that the unemployment
rate for Germany in this table was only 4% on average over each of
the three years shown on the table.
Obviously, Germany, you refer to it suffering a lot less and recovering
quicker than other Euro economies but I was still surprised. How
should we read the data point in the context of your provisioning so
far going forward? Are you actually using this as your baseline input
and, if so, is it a big driver to the lower than peer credit loss provisions
you’ve taken so far? So, any colour on that would be helpful.
And then my half question is just on capital. I don't recall if you've ever
disclosed your TRIM impact or quantified it. If not, is that a figure you
have to share as a sort of potential headwind in H2 and 2021? Thank
you.
Dixit Joshi 	Christy, I'll take sort of one, two and maybe four, and then leave IFRS
9 for James. So, just on SNLP, as you rightfully point out, SNLP was
negative at the end of Q1 for the obvious reasons around loan
drawdowns and reduced liquidity at the time.
We have been pleased with the way our liquidity modelling and the
way our management has functioned through the stress period and
thereafter. As we mentioned a quarter ago, this internal stress
measure for us gave us a much clearer view and was an earlier
indicator of movements than the regulatory stress test would.
We tend to think of the SNLP test as a conservative test in a variety of
ways. For example, to your point on countermeasures, it does not
include any potential to mobilise collateral and then finance that with
central banks.

-- 13 of 21 --

And so, during the second quarter, we've looked at executing on low-
cost measures that will improve the metric without compromising on
any of the conservative stance that we've taken. And, these measures
included mobilising some collateral, accessing TLTRO III and also some
client initiatives which would target targeted deposit optimisation
initiatives, which didn't impact liquidity directly but improved the
contractual term profile of our liquidity portfolio.
As a result of all of these, including some normalisation of conditions
in the client business, we've seen our SNLP improve by around €43
billion in the quarter. And, roughly speaking, that €43 billion can be
broken down into about €27 billion of improvement as a result of
increased liquidity, around €11 billion as a result of deposit
optimisation, 	and 	around 	€4 	billion 	on 	other 	methodology
enhancements.
So, in summary, I would say that I'm pleased with the performance.
We're very comfortable with our liquidity position, and it's a good
jump-off as we enter the second half of the year where there are some
uncertainties through that period.
The second question around MREL. As I've mentioned, with the €19
billion surplus and not needing to rely on any grandfathering, we're
well set to manage against some of the regulatory items that might
arise. There's a number of them that will come around and that we
factored into our forward planning for the first quarter of 2021.
Firstly, between now and the end of this year, we have factored in
fully the roll-off of all of the €17 billion of senior non-preferred that
falls under the one-year window next year.
And, then you have the regulatory changes which come in and the first
would 	be 	the 	switch 	from 	a 	TLOF-based 	to 	a 	RWA-based
methodology, which we expect to be around €4 billion to €6 billion of
impact. We expect the subordination requirement to increase, and
that's in line with the direction from the SRB.
Secondly, Brexit and the de-recognition of S&P MREL-eligible liabilities
or non-eligible liabilities would impact our ratio as well. And then,
thirdly, we will be taking active management decisions to reduce the
outstanding stack of capital market instruments that we have, which
will also reduce the MREL surplus. But, again, the starting point of €19
billion gives us tremendous flexibility as we enter that period.
And then, on your last question, the TRIM impact, which we were
previously anticipating in 2021 which might pose some downside in
the fourth quarter of this year, we estimate it in the region of around
€6.0 billion of RWA impact.

-- 14 of 21 --

James von Moltke 	And then briefly, on the macroeconomic forecast, you're right, that
4.1%, we've talked about the averaging that we've deployed as a
methodology to drive the IFRS 9 provisioning and the macroeconomic
variable that is captured in that three-year average for German
unemployment in the Bloomberg consensus as of June 30 is 4.1%. It
actually has a high point in that three-year period of 4.4% in Q4 this
year and so that's essentially the path that's built into the modelling
Now, your question is two things. One is the sensitivity of the portfolio
and obviously, German unemployment is one of the variables that
we're sensitive to, so we're clearly watching it carefully.
As to the scenario itself, one thing one needs to remember is just the
German social structure, including the availability of Kurzarbeit, a pre-
existing programme that enabled furloughing of workers.
So, one of the features, we think, in the German economy that will
lead to greater resilience and then ultimately less unemployment is
this idea that workers, their jobs are being supported by the
government in an interim period until they return. Now, obviously,
there's some risk to that outcome but, again, it remains a reasonable
central case, even with the recent economic data out of Germany.
Lee Street (Citigroup) 	Hello. Good afternoon, all. Three questions from me, please. On your
slide, you show you need about a 2% per annum revenue growth to
hit your €24.5 billion target. I'm just wondering, can you give us a bit
of colour by each division what revenue growth do you think you'll
actually do if you break it down between Corporate, Investment Bank,
Asset Management, etc. or any thoughts around that would be really
helpful.
Secondly, just on your Stage 2 balances of around €52 billion. How
should we think about that? What proportion can we sort of
realistically expect would translate from Stage 2 into Stage 3? That
would be really helpful to understand.
And then, just finally, you show in your slides, obviously, it looks like
you're taking a bigger proportion of provisions within Stage 3 relative
to Stages 1 and 2, that’s compared to other banks. Just any thoughts
around why that is and why that might be a little bit different with
Deutsche Bank as compared to some of the other banks there? That
would be my three questions. Thank you.
James von Moltke 	Lee, again, thanks for joining. I would refer you to the Investor Deep
Dive materials from December 10th. We gave some sense of what we
thought, for each of the four businesses, the path was to the 2022
RoTE targets.

-- 15 of 21 --

Now of course, we live in a dynamic world. And their paths will be
different over time, no doubt, and I would say what we've seen in the
last 12 months is a relative outperformance against our expectations,
of course, in Investment Banking and a more difficult path for
Corporate 	Bank 	and 	Private 	Bank, 	naturally 	given 	the 	rate
environment. And Asset Management, by and large, is performing
reasonably in-line with our expectations, although there was, of
course, a dip in market values in March through the end of May but
it's sort of recovered to where we were thinking.
So, there may be sort of shifts in what the pattern looks like but,
overall, we still are confident, as we mentioned, that we have a good
path to the €24.5 billion and a relatively modest sort of growth now
over the 2.5 years remaining. Admitting, of course, that we've
probably seen an over-indexing of the revenue environment in
Investment Bank in the first half of this year and the headwinds from
interest rates will persist.
In terms of Stage 2, I'm not sure, to the second part of your question,
exactly what you mean by the comparison to peers on Stage 3
composition. Stage 2, as you've seen, there was a significant increase,
a near doubling of that bucket for us over the year-to-date.
Now, interestingly, as we said in the first quarter calls, what you have
there is some actually very sort of strong credits but where there's
been rating movements that has caused us to downgrade them
between buckets. So, still relatively low expectations or probabilities
of default in those names, hence the significant increase in Stage 2
buckets and not as large an increase in the provisioning.
As to the likely movement between the buckets, that's of course the
major question that we all face. Moving to Stage 3 depends on those
Stage 3 events, essentially defaults or recognition that obligors are
unable to pay. We do have a baseline expectation built into our
forward guidance and, of course, the path of that is going to be a
critical driver of the CLPs going forward.
Lee Street 	All right, that makes sense. Just on the provisions, it just looked to me
like other banks seem to be taking a bit more Stage 1 and 2
provisioning relative to Stage 3, where you had a bit more coming
through into Stage 3 provisions relative to Stages 1 and 2 in the
quarter. That was just to understand if there's anything behind that.
James von Moltke 	Well, look, we had some Stage 3 events that we would call out as sort
of idiosyncratic, unrelated to COVID. Not clear to me that necessarily
continues into future periods. So, if you sort of subtract the €200-odd
million from - that we say is Stage 3 and that was COVID-related, you
had €300 million that wasn't. While somewhat consistent with recent

-- 16 of 21 --

quarters, I think that would probably be high relative to our current
expectations for the balance of the year.
Tom Jenkins (Jefferies) 	Yes, hello. Thank you very much, gents. I've got a question this time
on slide 20, going back to that one, if you'd be so kind.
You mentioned the exclusion of bonds issued under U.K. law following
Brexit starting 2021. No huge surprise, but I've been through pretty
much every single liquid tradable bond in that sector and I haven't
been able to find a UK law bond of note or a foreign or bond that
doesn't have German subordination provisions or German resolution
provisions.
Without asking you for the specific items, because I know that's
probably not what you want to do, but have you got any idea of the
quantum of bonds that will become excluded post '21 and is there a
schedule, a sliding scale, if you like, of the exclusion? Is it up until the
maturity in a certain period of time or a call date or that sort of thing?
If you could give me some colour on that, that would be great.
Dixit Joshi 	Sure, happy to. From an MREL perspective, we have about €5 billion
of bonds that we would look to derecognise in January of next year.
Again, very comfortable with that, as you can tell. It's very much baked
into our glide path and funding requirements and our forward view
on MREL. So, we're not just looking to the €19 billion surplus but it's
really how that evolves over the next few periods.
I would have given you the items, but we'll leave that to Jonathan to
do subsequently if that's something that we would like to do. It is
something that we can manage quite comfortably.
We also have tools at our disposal, which we wouldn't really trigger
right now. For example, consent solicitations on LMEs or exchange
offers, etc. Just given the surplus that we have and the starting
position we have, we wouldn't see a need to do that right now.
So, we're factoring it in, and we're managing towards that. We're
cognisant of both the regulatory items like this as well as the roll-off
of bonds that fall under one year and it's managing all of those. I hope
that's helpful, Tom.
Tom Jenkins 	Yes, that’s great. So, that €5 billion, is it mostly or entirely in the senior
non-preferred stack or is the senior preferred that you can include in
your sort of MREL qualification rather than anything specifically
subordinated?
Dixit Joshi 	No, senior non-preferred.
Tom Jenkins 	Senior non-preferred. Fair enough. And then, just in connection with

-- 17 of 21 --

that, very quickly, obviously, seeing UK law bonds excluded post Jan
'21, I assume and I know what assume means but I assume that,
therefore, we can take a similar stance on non-EU bonds post-2021 as
per sort of previous, i.e., if you've got a Cayman Islands, Delaware law,
New York law or Delaware law with New York law on subordinated
guarantee, that sort of thing, does that get excluded post-2021 in its
entirety? There's no attempt to try and keep that on in any different
way, shape or form?
Dixit Joshi 	No, this is a specific comment that's related to, really, Brexit and
really, de-recognition related to Brexit, i.e., the €5 billion is really UK
law-specific.
Tom Jenkins 	Yes, but all other legal frameworks and issues around those still stand?
Is that correct?
Dixit Joshi 	That’s right.
Jakub Lichwa (RBC) 	Hi, there. Thanks for doing the call. One question is about the NPS
supply. I noticed you adjusted it. You mentioned, I think, in the Q1 call
that part of the reduction was due to Moody's methodology
adjustment. I think they are thinking of delaying it or doing some U-
turn on it, as published in June. Have you already included it in the
revised expectations now? So, that will be one.
And a second, on the Stage 2. You did say that the rating downgrade
drives the finance of this bucket but are you able to comment what
sort of rating gets you to Stage 2 or what is the probability of default
you assign that gets you from Stage 1 to Stage 2, please? That’s it.
Thank you.
Dixit Joshi 	Jakub, on LGF we have noted that Moody's timeline has been pushed
out. It is our view that the consultation as envisaged and, quite frankly,
our expectation of consultation as we see has the likelihood of having
some upside positive impact for us. Let's not forget that's very much
a forward-looking measure, not necessarily a point in time measure,
so it is something that we watch closely.
As you know from previous calls, we're very sensitive to our ratings
and so protecting the rating remains important and including LGF. In
previous quarters, we've messaged that we've continued to issue
partly to ensure that we maintain ratings agency criteria. That will be
no different, whether with the current LGF requirements or any
potential improvements that we get from LGF, as well.
James von Moltke 	Jakub, on Stage 2, actually, we put in a slide on this in our Risk Deep
Dive from June 18 th
, slide 20. I guess, two ways to triangulate. The
triggers are an increase in lifetime probably of default or a rating

-- 18 of 21 --

downgrade, transfer to workout, forbearance measures, 30 days past
due or a watchlist inclusion.
So, there's a range of Stage 2 triggers and actually, we watch the
trends of those things as well as obviously the event itself, so it's
something we are watching carefully. One of the interesting things, I
think, of the presentation of our slide that was referred to earlier, is
the range of the PD bucket that is in each of them, which is hopefully
also each of the PDs that correspond to each of the ratings buckets, I
think, also gives you a sense of what that looks like.
James Hyde (PGIM) 	Hi, James. Hi, Dixit. 	I have a question that's really a follow-up to
Jakub’s and earlier, Lee's question. You have what is probably a drop
in the ocean compared with UK and Southern European banks, €16
billion of moratoria and forbearance measures. I just wanted to know,
are these €16 billion one-for-one included in the €52 billion Stage 2?
James von Moltke 	No, they're not. Because, specifically, the moratoria guidance is
written that if the obligor prior to the onset of COVID was performing,
you would not include the availing themselves of a moratorium as
being a staging driver. But, there's, obviously, other movements in the
portfolio that are COVID-related that would have led to the Stage 2
but the moratoria are not, themselves, drivers. There are certain
instances where we give forbearance, so the voluntary forbearance
measures that we provide can obviously influence our staging.
James Hyde 	The key question in all this and I suppose what Lee was trying to get
at is the, effectively, your full year provision guidance means €1.5-2
billion, which is sort of really not much for a crisis and I'm trying to
think whether these moratoria and forbearance loans would be the
trigger factor to make that go above €2 billion, given the fact that your
pre-provision profitability is not much above that.
James von Moltke 	The total of €16 billion, which is an addition of three unlike things. I
don't think of as being especially meaningful as a guide to that. I think
the driver is simply what Stage 3 events take place that would result
in incremental provisioning relative to the Stage 2 provisions against
the same credits that we currently hold, and then what happens in the
migration into and out of.
And then, of course, macroeconomic variables. As the outlook moves
around, either improves or deteriorates, that will influence what we
refer to as the forward-looking indicators. So, the provisions that we
take, principally in Stage 2, is driven by the change in outlook.
James Hyde 	Thanks. And, finally, €32 billion of CRE. Is it a meaningful proportion
of that Stage 2?

-- 19 of 21 --

James von Moltke 	I'm not going to disclose the amount that is in Stage 2. As I said earlier,
it's a portfolio we're watching carefully. In the measures that we have
taken, whether it's offering lender concessions to the sponsors, that
portfolio would certainly fall in the list where we have taken such
measures.
By and large, I'd also add we've seen very, I think, constructed sponsor
behaviour in that portfolio. So, where lenders have been providing
restructurings or forbearance, often it's been associated with
incremental equity provided by the sponsors. So, it is absolutely a
portfolio that a certain amount will be in Stage 2 and some in Stage 3
and needs to be monitored carefully.
James Hyde 	Great. Thank you very much. Have a great weekend.
James von Moltke 	Thanks, James. Thanks for joining.
Operator 	At this time, there are no further questions. I hand back to Philip
Teuchner, for closing comments.
Philip Teuchner 	Thank you very much, Emma, and thank you all for joining the call
today. You know where the IR team is if you have further questions
and we look forward to talking to you soon. Goodbye.
Disclaimer
This transcript contains forward-looking statements. Forward-looking statements are statements
that are not historical facts; they include statements about our beliefs and expectations and the
assumptions underlying them. These statements are based on plans, estimates and projections
as they are currently available to the management of Deutsche Bank. Forward-looking
statements therefore speak only as of the date they are made, and we undertake no obligation to
update publicly any of them in light of new information or future events.
By their very nature, forward-looking statements involve risks and uncertainties. A number of
important factors could therefore cause actual results to differ materially from those contained in
any forward-looking statement. Such factors include the conditions in the financial markets in
Germany, in Europe, in the United States and elsewhere from which we derive a substantial
portion of our revenues and in which we hold a substantial portion of our assets, the development
of asset prices and market volatility, potential defaults of borrowers or trading counterparties, the
implementation of our strategic initiatives, the reliability of our risk management policies, proce-
dures and methods, and other risks referenced in our filings with the U.S. Securities and
Exchange Commission. Such factors are described in detail in our SEC Form 20-F of 20 March
2020 under the heading “Risk Factors.” Copies of this document are readily available upon
request or can be downloaded from www.db.com/ir.
This transcript also contains non-IFRS financial measures. For a reconciliation to directly
comparable figures reported under IFRS, to the extent such reconciliation is not provided in this
transcript, refer to the Q2 2020 Financial Data Supplement, which is available at www.db.com/ir.

-- 20 of 21 --

This transcript is provided solely for information purposes and shall not be construed as a
solicitation of an offer to buy or sell any securities or other financial instruments in any jurisdiction.
No investment decision relating to securities of or relating to Deutsche Bank AG or its affiliates
should be made on the basis of this document. Please refer to Deutsche Bank’s annual and interim
reports, ad hoc announcements under Article 17 of Regulation (EU) No. 596/2014 and filings
with the U.S. Securities Exchange Commission (SEC) under Form 6-K.

-- 21 of 21 --